WeChat Mini Program
Old Version Features

Re‐estimation of Drug‐specific Amyloid Removal Parameters and the Rate Constant for Pathogenic Tau Turnover Brings the Q‐ATN Model into Better Alignment with Recent Phase 3 Data from Gantenerumab and Lecanemab

Norman A Mazer,Dominik Lott,Hans Peter Grimm,Matthias Machacek,Frank Boess,Ronald Gieschke,Gregory Klein,Monika Baudler,Rachelle S. Doody

Alzheimer's &amp Dementia（2023）

Cited 0|Views5
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined